Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Intuitive Surgical
ISRG
Intuitive Surgical
Da Vinci 5 Rollout Will Leverage Aging And Digital Trends
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 27 Analysts
Published
15 Jun 25
Updated
14 Jul 25
1
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$675.00
30.1% undervalued
intrinsic discount
14 Jul
US$471.85
Loading
1Y
1.4%
7D
-2.4%
Author's Valuation
US$675.0
30.1% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$675.0
30.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
15b
2014
2017
2020
2023
2025
2026
2028
Revenue US$14.6b
Earnings US$4.1b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
12.13%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.46%
Calculation
US$4.07b
Earnings '28
x
74.63x
PE Ratio '28
=
US$303.85b
Market Cap '28
US$303.85b
Market Cap '28
/
367.77m
No. shares '28
=
US$826.20
Share Price '28
US$826.20
Share Price '28
Discounted to 2025 @ 7.04% p.a.
=
US$673.59
Fair Value '25